Medicure Stock Revenue
| MCUJF Stock | USD 0.70 0.02 2.94% |
Medicure fundamentals help investors to digest information that contributes to Medicure's financial success or failures. It also enables traders to predict the movement of Medicure Pink Sheet. The fundamental analysis module provides a way to measure Medicure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicure pink sheet.
Medicure |
Medicure Company Revenue Analysis
Medicure's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Medicure Revenue | 21.74 M |
Most of Medicure's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Medicure reported 21.74 M of revenue. This is 99.71% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.77% higher than that of the company.
Medicure Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicure's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medicure could also be used in its relative valuation, which is a method of valuing Medicure by comparing valuation metrics of similar companies.Medicure is currently under evaluation in revenue category among its peers.
Medicure Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 5.67 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 26.70 % | |||
| Shares Owned By Institutions | 23.51 % | |||
| Number Of Shares Shorted | 15.08 K | |||
| Price To Earning | 11.45 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.37 X | |||
| Revenue | 21.74 M | |||
| Gross Profit | 12.71 M | |||
| EBITDA | 2.42 M | |||
| Net Income | (727 K) | |||
| Cash And Equivalents | 4.83 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 1.02 M | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 1.47 X | |||
| Book Value Per Share | 2.04 X | |||
| Cash Flow From Operations | 3.99 M | |||
| Short Ratio | 1.77 X | |||
| Earnings Per Share | 0.21 X | |||
| Price To Earnings To Growth | (23.59) X | |||
| Target Price | 0.13 | |||
| Number Of Employees | 12 | |||
| Beta | 1.05 | |||
| Market Capitalization | 9.24 M | |||
| Total Asset | 28.41 M | |||
| Retained Earnings | (89.95 M) | |||
| Working Capital | 5.11 M | |||
| Current Asset | 12.56 M | |||
| Current Liabilities | 7.45 M | |||
| Z Score | 1.2 | |||
| Net Asset | 28.41 M |
About Medicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.